We are live on ! Find out more
PDLI

PDL BioPharma, Inc.
PDLI

Delisted

PDLI was delisted on the 30th of December, 2020.

Back to rankings

11 hedge funds and large institutions have $36.7M invested in PDL BioPharma, Inc. in 2021 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

65% less capital invested

Capital invested by funds: $106M → $36.7M (-$69.2M)

67% less funds holding

Funds holding: 33 → 11 (-22)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 21

Holders
11
Holders Change
-22
Holders Change %
-66.67%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
21
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PPA
Parametric Portfolio Associates
Washington
+$2.07K

Top Sellers

Rank Fund Capital Flow
1
SPC
Silver Point Capital
Connecticut
-$58.7M
2
KBC Group
KBC Group
Belgium
-$2.16M
3
GCIA
Gabelli & Co Investment Advisers
New York
-$1.56M
4
JC
JBF Capital
Colorado
-$1.34M
5
GF
Gabelli Funds
New York
-$1.27M
Name Holding Trade Value Shares
Change 		Change in
Stake
PWAM
1
Park West Asset Management
California
$36.2M – – –
PPA
2
Parametric Portfolio Associates
Washington
$351K +$2.07K +837 +0.6%
Public Employees Retirement Association of Colorado
3
Public Employees Retirement Association of Colorado
Colorado
$141K – – –
SPC
4
Silver Point Capital
Connecticut
– -$58.7M -23,783,273 Closed
GCIA
5
Gabelli & Co Investment Advisers
New York
– -$1.56M -633,700 Closed
JC
6
JBF Capital
Colorado
– -$1.34M -543,990 Closed
GF
7
Gabelli Funds
New York
– -$1.27M -512,534 Closed
CCM
8
Context Capital Management
California
– -$1.15M -465,172 Closed
California Public Employees Retirement System
9
California Public Employees Retirement System
California
– -$625K -252,971 Closed
Russell Investments Group
10
Russell Investments Group
United Kingdom
– -$485K -196,783 Closed
HW
11
Hancock Whitney
Mississippi
– -$464K -187,757 Closed
KBC Group
12
KBC Group
Belgium
– -$2.16M -158,664 Closed
B
13
Bellecapital
Switzerland
– -$267K -108,025 Closed
FIA
14
FNY Investment Advisers
New York
– -$247K -100,000 Closed
FIM
15
Freedom Investment Management
Connecticut
– -$135K -54,735 Closed
DekaBank Deutsche Girozentrale
16
DekaBank Deutsche Girozentrale
Germany
– -$133K -50,100 Closed
TRCT
17
Tower Research Capital (TRC)
New York
– -$123K -49,918 Closed
Victory Capital Management
18
Victory Capital Management
Texas
– -$43K -17,605 Closed
BNP Paribas Financial Markets
19
BNP Paribas Financial Markets
France
– -$32.6K -13,190 Closed
Simplex Trading
20
Simplex Trading
Illinois
– -$23K -9,482 Closed
PWPS
21
Pinnacle Wealth Planning Services
Ohio
– -$9K -3,806 Closed
OSAM
22
O'Shaughnessy Asset Management
Connecticut
– -$4K -1,575 Closed
Barclays
23
Barclays
United Kingdom
– -$1K -596 Closed
FCH
24
Freestone Capital Holdings
Washington
– -$277 -112 Closed

PDLI Hedge Fund Activity: Q1 2021 in Review

11 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in PDL BioPharma, Inc. (PDLI) for Q1 2021, worth a combined $36.7M — down 65% from $106M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of PDLI and 0 opened new positions — a net loss of 21 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was Parametric Portfolio Associates, adding an estimated $2.07K. The largest seller was Silver Point Capital, exiting entirely with an estimated $58.7M sold.

  • 11 institutional investors held PDL BioPharma, Inc. (PDLI) as of Q1 2021, down from 33 in Q4 2020.
  • Funds reported $36.7M of PDL BioPharma, Inc. stock for Q1 2021, down 65% quarter-over-quarter.
  • 0 funds opened new PDL BioPharma, Inc. positions in Q1 2021 and 21 closed out, a net change of -21 holders.
  • The largest PDL BioPharma, Inc. buyer in Q1 2021 was Parametric Portfolio Associates, an estimated $2.07K added.
  • The largest PDL BioPharma, Inc. seller in Q1 2021 was Silver Point Capital, an estimated $58.7M sold.

Based on aggregated 13F filings for Q1 2021.